Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
domingo, octubre 25
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Astrana Health Inc
ASTH
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$37.45
-0.56
-1.47%
Últ. Act.: Oct 23, 4:00 PM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Ganancias:
Beneficios de Q3 2026 dentro de 12 días de ahora en jue nov 5th, después del cierre del mercado
Astrana Health Financials
Astrana Health (ASTH) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.004B Est
Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $4.004 billion estimate.
Benzinga Newsdesk
PRO
Astrana Health Sees Q3 Sales $1.000B-$1.030B vs $1.021B Est
Astrana Health (NASDAQ:ASTH) sees Q3 sales of $1.000 billion-$1.030 billion vs $1.021 billion analyst estimate.
Benzinga Newsdesk
PRO
Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.001B Est
Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $4.001 billion estimate.
Benzinga Newsdesk
PRO
Astrana Health Q2 EPS $0.40 Beats $0.34 Estimate, Sales $972.520M Miss $985.716M Estimate
Astrana Health (NASDAQ:ASTH) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.34 by 17.65 percent. This is a 110.53 percent increase over earnings of $0.19 per share from
Benzinga Newsdesk
PRO
Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $3.984B Est
Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $3.984 billion estimate.
Benzinga Newsdesk
PRO
Astrana Health Sees Q2 Sales $965.000M-$1.000B vs $973.326M Est
Astrana Health (NASDAQ:ASTH) sees Q2 sales of $965.000 million-$1.000 billion vs $973.326 million analyst estimate.
Benzinga Newsdesk
